This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Theravance, Inc. CEO Discusses Q2 2012 Earnings Results - Earnings Call Transcript

Theravance, Inc. (THRX)

Q2 2012 Earnings Call

July 31, 2012 5:00 pm ET


Cheryllyn De Ocampo – Investor Relations Associate

Rick E. Winningham – Chairman of the Board & Chief Executive Officer

Renee Gala – Senior Director of Financial Planning & Analysis


[Rodney Gao] – Sanford Bernstein

Analyst Ken Cacciatore – Cowen & Company

Howard Liang – Leerink Swann, LLC.

Analyst David Friedman – Morgan Stanley

Analyst for Thomas Russo – Robert W. Baird & Co., Inc.



Ladies and gentlemen at this time I’d like to welcome everyone to the Theravance conference call to review results for the quarter ended June 30, 2012. During the presentation all participants will be in a listen only mode. A question and answer session will follow the company’s formal remarks. (Operator Instructions) Today’s conference call is being recorded. Now, I’d like to turn the call over to Cheryllyn De Ocampo, Investor Relations Associate.8

Cheryllyn De Ocampo

We me on the call today are Rich Winningham, our Chief Executive Officer and Renee Gala, Senior Director of Financial Planning & Analysis. Renee is filling in for Mike Aguiar our Senior Vice President and Chief Financial Officer who is on vacation.

First, Rick will review highlights from the quarter and then Renee will review our financial results. Following our comments we will open up the call for questions. Earlier today Theravance issued a press release detailing second quarter 2012 financial results and recent corporate developments. A copy of the press release can be downloaded from our website or you can call investor relations at 650-808-4100 and we’ll be happy to assist you.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.37 -1.50%
FB $116.46 -0.23%
GOOG $691.80 0.11%
TSLA $238.69 -3.60%
YHOO $36.36 -0.63%


Chart of I:DJI
DOW 17,703.69 -127.07 -0.71%
S&P 500 2,060.38 -15.43 -0.74%
NASDAQ 4,772.0860 -33.2050 -0.69%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs